Yahoo Finance – How Open Orphan is testing vaccines through intentional infection
Open Orphan #ORPH Executive Chairman Cathal Friel joins Yahoo Finance Live to discuss how his company is testing vaccines through intentional infection. ….ANJALEE KHEMLANI: Right, yeah, I want to get into all the potential. But let’s walk back and talk about, because the last time we spoke, you were just getting into the COVID trial. So […]
Alan Green on Open Orphan #ORPH, Blencowe Resourses #BRES & Logistics Development Group #LDG
Alan Green CEO of Brand Communications talks about: Open Orphan #ORPH, Blencowe Resources #BRES & Logistics Development Group #LDG https://audioboom.com/posts/7945231-alan-green-on-open-orphan-blencowe-resourses-logistics-development-group
Open Orphan #ORPH – £5.7m Influenza human challenge study contract win
Open Orphan (AIM: ORPH), a rapidly growing specialist clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, announces that hVIVO, a subsidiary of Open Orphan plc, has signed a £5.7m contract with a specialist biotechnology company developing therapeutics for respiratory viral infections, to test its antiviral product […]
Open Orphan #ORPH – Notice of Results, Analyst Briefing and Investor Presentation
Open Orphan (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that its interim results for the six-month period ended 30 June 2021 will be released on Monday, 20 September 2021. Analyst Briefing A briefing open to analysts will […]
Open Orphan #ORPH – Positive results from RSV Human Challenge Study
RSV Human Challenge Study conducted by hVIVO yields positive results Open Orphan plc (AIM: ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , notes the announcement dated 1 September 2021 from Barvarian Nordic A/S (OMX: BAVA), reporting positive results received from a human […]
Alan Green talks Open Orphan #ORPH, Aquis #AQX & Ananda Developments #ANA
Alan Green talks Open Orphan #ORPH, Aquis #AQX & Ananda Developments #ANA
Researchers Infect Volunteers With Coronavirus, Hoping to Conquer Covid-19 – Wall Street Journal
By Jenny Strasburg Sept. 4, 2021 530 am ET LONDON—Much of the world spent the past year taking vaccines and wearing masks to evade Covid-19. In the U.K., almost four dozen volunteers have had the virus dripped into their noses by syringe in clinical experiments. So-called human challenge studies—which intentionally expose healthy people to viruses […]
The Times – Drug Tester’s £8m Contract Win
Tom Howard Market Report – Open Orphan #ORPH shares rose after the AIM company bagged a new contract worth £8.1m with one of Europe’s biggest drugmakers… Link here to read the full Times article
Open Orphan #ORPH – £8.1m Asthma Human Challenge Study Contract Win
Open Orphan (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, announces that hVIVO, a subsidiary of Open Orphan plc, has signed an £8.1m contract with a major global pharmaceutical company to test its inhaled human rhinovirus (hRV) antiviral product using […]
Open Orphan #ORPH – Development of Controlled Human Malaria Infection Human Challenge Study
Open Orphan plc (AIM: ORPH), a rapidly growing specialist clinical research organisation (CRO) and world leader in testing vaccines and antivirals using human challenge clinical trials, announces that its subsidiary, hVIVO, has developed a Controlled Human Malaria Infection (“CHMI”) challenge model, both strengthening and further diversifying the Company’s world leading portfolio of viral challenge study models. […]